|
Summary of recurrence-free survival (RFS) for 69 patients with high-grade TCC.
|
RFS
|
All
Patients
|
Ag
Negative Patients
|
Ag
Positive Patients
|
|
Median
RFS (95% CI)
|
24.4
mo (15.8, 70.2)
|
24.4
mo (17.9, 70.2)
|
Not
reached
|
|
One-year
RFS (95% CI)
|
68%
(57, 79)
|
69%
(54, 85)
|
67%
(50, 83)
|
|
Two-year
RFS (95% CI)
|
51%
(38, 64)
|
51%
(33, 69)
|
52%
(34, 70)
|
|
